ArticleMethods in molecular biology (Clifton, N.J.)2026
Immunohistochemical Staining Protocol of Enteric Glial Cells in Myenteric Plexi.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the development of several genetic approaches to visualize enteric glia within the enteric nervous system (ENS), multiple fluorescence labeling remains an essential tool for simultaneously identifying several target molecules. Fluorescence microscopy is widely used to differentiate between distinct glial subtypes based on their morphological appearance and chemical content, with a high degree of specificity. The dynamic nature of enteric glial cells drives extensive changes in morphology and/or the expression of markers, such as GFAP and S100β, in response to extracellular cues and under distinct physiopathological conditions. These changes depend on factors such as the type and severity of the insult, the time elapsed following the insult, the type of enteric glia, their location within the intestine, and the specific molecular signals they receive. In this context, immunofluorescence provides a combinatorial code that defines the extent of phenotypical changes in distinct glial subtypes based on their protein expression. In this chapter, we describe a protocol designed to immunolabel enteric glia in whole-mount circular muscle myenteric plexus (CMMP) preparations and provide an overview of the main sensitive steps that may affect the quality of the immunolabeling.
Indexed as
Identifiers
41028621What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.